PHIA Koninklijke Philips N.V.

Philips introduces industry-first cath lab integration that automatically synchronizes pre-operative CT with C-arm movement, paving the way for CT-guided PCI

Philips introduces industry-first cath lab integration that automatically synchronizes pre-operative CT with C-arm movement, paving the way for CT-guided PCI



October 27, 2025                                                    



New integration of Philips Advanced Visualization Workspace* with the Azurion image-guided therapy platform automatically synchronizes CT images with C-arm movement, supporting workflow efficiency and additional anatomical insights in PCI procedures1

San Francisco, USA and Amsterdam, The Netherlands At the annual Transcatheter Cardiovascular Therapeutics (TCT 2025) meeting, (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced an industry-first innovation that integrates pre-operative CT data directly into the cath lab workflow. This new capability, available through the integration of Philips’ Advanced Visualization Workspace (AVW) with the Azurion image-guided therapy system, marks a first step towards CT-guided percutaneous coronary intervention (PCI), a minimally invasive procedure to open narrowed coronary arteries and restore blood flow to the heart.



The new capability, Follow C-arm, automatically synchronizes the 3D reconstruction of coronary arteries with the movement of the Azurion C-arm. As the C-arm angulation changes, the CT volume rotates in real time to match, giving interventionalists the 3D anatomical view without manual interaction. This seamless connection helps clinicians combine the detailed insights of CT imaging with the flexibility of live X-ray guidance inside the cath lab. The combined AVW–Azurion approach aims to provide enhanced anatomical insights to guide complex PCI procedures, publications have shown that leveraging CCTA may lead to reduction in contrast medium use and radiation dose during interventions.1



Supporting the shift towards CT-guided PCI


Coronary computed tomography angiography (CCTA) is increasingly used in global clinical guidelines as a first-line tool for the diagnosis and planning of coronary artery disease. With more patients now arriving at the cath lab with prior CT scans, physicians are seeking ways to incorporate this information into their interventional workflows. By integrating CT data directly into Azurion, Philips is helping interventionalists expand the use of CT beyond diagnosis and planning, supporting a future in which CT-guided PCI becomes standard practice.



“By bringing pre-operative CT into the cath lab and linking it directly to the movement of the C-arm, Philips is delivering an industry-first that helps interventionalists prepare for and execute PCI procedures with greater confidence,” said Mark Stoffels, Business Leader Image-Guided Therapy Systems at Philips. “This seamless integration is a significant step towards CT-guided PCI, aligning with our commitment to improving workflow efficiency and advancing patient care in interventional cardiology.”



The launch builds on the global success of Philips’ Azurion image-guided therapy platform, the world’s leading system designed for seamless integration of advanced applications. Since its introduction in 2017, Azurion has been used to treat more than 6.4 million patients annually in over 80 countries, helping physicians perform minimally invasive procedures with greater confidence and efficiency.



For more information about Philips’ presence at TCT, please visit the .

For further information, please contact:



Joost Maltha

Philips Global External Relations

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.



Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,800 employees with sales and services in more than 100 countries. News about Philips can be found at .

Disclaimer: * The Follow C-arm capability as part of Philips Advanced Visualization Workspace may not be available in all markets. Please contact your Philips representative for more details.

Reference: 1. J Cardiovasc Comput Tomogr. 2025 May-Jun;19(3):277-290.

Attachments



EN
27/10/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips introduces industry-first cath lab integration that automatica...

Philips introduces industry-first cath lab integration that automatically synchronizes pre-operative CT with C-arm movement, paving the way for CT-guided PCI October 27, 2025                                                    New integration of Philips Advanced Visualization Workspace* with the Azurion image-guided therapy platform automatically synchronizes CT images with C-arm movement, supporting workflow efficiency and additional anatomical insights in PCI procedures1 San Francisco, USA and Amsterdam, The Netherlands – At the annual Transcatheter Cardiovascular Therapeutics (TCT 2025) ...

 PRESS RELEASE

Philips announces 5,000th Zenition mobile C-arm system installation, a...

Philips announces 5,000th Zenition mobile C-arm system installation, advancing access to high-quality, efficient surgical and interventional care worldwide October 8, 2025 Global adoption milestone underscores innovation in mobile C-arm surgical and interventional imaging, with more than 15 million patients treated in 170+ countries every year Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the 5,000th installation of its Philips Zenition mobile surgery imaging system at Kolín Regional Hospital in the Czech Republic. Since its la...

 PRESS RELEASE

Philips unveils latest CT and MR innovations in radiation therapy, adv...

Philips unveils latest CT and MR innovations in radiation therapy, advancing precision cancer care at ASTRO 2025 September 26, 2025 New Rembra RT and Areta RT [1] CT platforms drive accuracy and efficiency in radiation therapy with advanced workflows and long-term valuePhilips debuts helium-free [2] BlueSeal RT 1.5T 70cm MR system with AI-powered SmartSpeed Precise, expanding its leadership in sustainable MR for radiation oncology Amsterdam, the Netherlands – At the American Society for Radiation Oncology () 2025 Annual Meeting, (NYSE: PHG, AEX: PHIA), a global leader in health technolog...

 PRESS RELEASE

Philips joins Optum Healthcare’s network as a preferred provider in th...

Philips joins Optum Healthcare’s network as a preferred provider in the USA September 25, 2025 Philips’ ambulatory and diagnostic solutions and services are now available to 3.4 million Optum policyholders for enhanced outpatient cardiac monitoring Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has entered a national partnership in the USA with Optum Healthcare. The inclusion of Philips’ (MCOT) and Philips Extended Holter (ePatch) in the network is designed to enable earlier detection of cardiac conditions and timely cli...

 PRESS RELEASE

Philips intends to extend maturity of forward purchases of 4 million s...

Philips intends to extend maturity of forward purchases of 4 million shares for long-term incentive plans September 15, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA) announces today that it intends to extend the settlement of two forward contracts for 2 million long-term incentive plans shares each as part of the share repurchase program on June 14, 2023. The planned extension will postpone the original maturity dates in Q4 2025 by one year to a new maturity date in Q4 2026. Further details will be available via this . For further information, please contact:Michael FuchsPhil...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch